These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Effect of interferon on malignant brain tumor]. Wakabayashi T; Yoshida J; Kobayashi T; Kageyama N; Kanzaki M Gan To Kagaku Ryoho; 1982 Aug; 9(8):1400-6. PubMed ID: 7184455 [TBL] [Abstract][Full Text] [Related]
47. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells. Stutman O; Lattime EC; Figarella EF Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250 [TBL] [Abstract][Full Text] [Related]
48. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230 [TBL] [Abstract][Full Text] [Related]
49. Tumor degeneration by human embryonic fibroblasts and its enhancement by interferon. Imanishi J; Hoshino S; Matsuoka H; Uemura H; Imanishi T; Tanaka A; Nishino H; Kishida T Cancer Res; 1983 Sep; 43(9):4323-6. PubMed ID: 6307510 [TBL] [Abstract][Full Text] [Related]
50. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells. Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362 [TBL] [Abstract][Full Text] [Related]
51. Tumor suppressive action of indomethacin is NK-cell-independent. Cvetkovska E; Asea A; Hellstrand K; Edström S Anticancer Res; 1997; 17(5A):3403-7. PubMed ID: 9413179 [TBL] [Abstract][Full Text] [Related]
52. [Tumor killing in cooperation with actinomycin D and neutrophils]. Yamazaki M Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):684-8. PubMed ID: 3963839 [TBL] [Abstract][Full Text] [Related]
53. gamma-Interferon plays a key role in T-cell-induced tumor regression. Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364 [TBL] [Abstract][Full Text] [Related]
54. [Distribution of BCG antigens in mouse-tumor cells]. Sasaki J; Sawamura D; Kamiya S; Yamatani S; Satoh K; Fukushi K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1074-6. PubMed ID: 3516075 [No Abstract] [Full Text] [Related]
56. [Action of phospholipids and gangliosides on tumor cell sensitivity to the cytostatic and membrane-toxic action of splenic effectors]. Bogdashin IV; Shvets VI; Krasnopol'skiĭ IuM; Fuks BB Biull Eksp Biol Med; 1985 Aug; 100(8):237-9. PubMed ID: 3875373 [TBL] [Abstract][Full Text] [Related]
57. In vitro activation of murine macrophages and their increased capacity to lyse target cells after cis-platin treatment. Sodhi A; Bhatia P Indian J Exp Biol; 1986 Sep; 24(9):565-72. PubMed ID: 3557557 [No Abstract] [Full Text] [Related]
58. Thymic lymphomas mediate non-MHC-restricted, TNF-dependent lysis of the murine sarcoma WEHI-164. Lattime EC; Stutman O Cell Immunol; 1991 Aug; 136(1):69-79. PubMed ID: 2060025 [TBL] [Abstract][Full Text] [Related]
59. Neoplasms in mice neonatally inoculated with rat thymus antiserum and fed benzo(a)pyrene. Rigdon RH; Neal J; Anigstein D; Anigstein L Cancer Res; 1967 Dec; 27(12):2318-23. PubMed ID: 6082282 [No Abstract] [Full Text] [Related]
60. Mouse histocompatibility genetics and tumor immunology. Klein G Prog Clin Biol Res; 1981; 45():197-211. PubMed ID: 7017752 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]